Predicting Response to Mesalamine Induction Therapy in Children Newly Diagnosed with Mild-to-Moderate Ulcerative Colitis: The Protect Study - Lee A. Denson, Sonia Davis, David R. Mack, Brendan M. Boyle, Anne M. Griffiths, Neal S. Leleiko, Cary G. Sauer, David J. Keljo, James Markowitz, Susan S. Baker, Joel R. Rosh, Robert N. Baldassano, Ashish S. Patel, Marian D. Pfefferkorn, Anthony Otley - Dissemin

Language
Login

Published in

Publishing House Zaslavsky, Gastroenterology, 5(152), p. S956-S957

DOI: 10.1016/s0016-5085(17)33251-1

Links

Publishing House Zaslavsky

Tools

Export citation

Search in Google Scholar

Predicting Response to Mesalamine Induction Therapy in Children Newly Diagnosed with Mild-to-Moderate Ulcerative Colitis: The Protect Study

Journal article published in 2017 by Lee A. Denson, Sonia Davis, David R. Mack, Brendan M. Boyle, Anne M. Griffiths, Neal S. Leleiko, Cary G. Sauer, David J. Keljo, James Markowitz, Susan S. Baker, Joel R. Rosh, Robert N. Baldassano, Ashish S. Patel, Marian D. Pfefferkorn, Anthony Otley and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Green circle

Published version: archiving allowed

Upload

Policy details

Data provided by

SHERPA/RoMEO